FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:2391-2393 December 7, 2006 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The Nobel Prize in Physiology or Medicine was awarded this year to Andrew Fire (Stanford University School of Medicine) and Craig Mello (University of Massachusetts Medical School) for their discovery of a new form of gene silencing. Nearly 9 years ago, Fire and Mello and their colleagues reported that exposing cells of the nematode Caenorhabditis elegans to double-stranded RNA resulted in specific and efficient gene silencing.¹ They also observed that double-stranded RNA is far more potent than sense or antisense RNA in silencing the gene that shares its sequence, and they dubbed the silencing process "RNA interference" (RNAi). Because RNAi . . . [Full Text of this Article]

Source Information

Dr. Bernards is the head of the Division of Molecular Carcinogenesis at the Netherlands Cancer Institute, Amsterdam.

This article has been cited by other articles:

• Newman, J. H., Phillips, J. A. III, Loyd, J. E. (2008). Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies. ANN INTERN MED 148: 278-283 [Abstract] [Full Text]